What is included with this book?
Contributors | p. ix |
Preface | p. xi |
Caspases in Myocardial Infarction | |
Abstract | p. 1 |
Introduction | p. 2 |
Apoptosis and the Heart | p. 3 |
Caspases | p. 3 |
Activation of Caspases | p. 4 |
Activation of Caspases in the Heart | p. 5 |
Functional Significance of Caspases | p. 6 |
Caspases for Detection of Apoptosis | p. 9 |
Apoptosis and Caspases in MI | p. 11 |
Apoptosis of Cardiomyocytes in Ventricular Remodeling After MI | p. 14 |
Apoptosis of Other Cell Types in the Evolution of Fibrous Scar | p. 15 |
Anti-Caspase Treatment | p. 18 |
Conclusion | p. 23 |
References | p. 23 |
Deamidated Gliadin Peptides as Targets for Celiac Disease-Specific Antibodies | |
Abstract | p. 36 |
Introduction | p. 36 |
Prolamins as Cereal Storage Proteins | p. 37 |
Pathogenesis of CD | p. 38 |
Serological Diagnosis of CD | p. 42 |
Gliadin Antibodies of CD Patients Recognize Deamidated Gliadin | p. 45 |
Enhanced Diagnostic Potential of Glutamine-Glutamic Acid Substituted Gliadin-Analogous Peptides | p. 47 |
Does Epitope Specificity of Gliadin Antibodies of CD Patients Mirror Substrate Specificity of tTG? | p. 49 |
Relation Between B- and T-Cell Epitopes of Gliadin | p. 51 |
Conclusions | p. 52 |
References | p. 53 |
Urokinase Receptor Variants in Tissue and Body Fluids | |
Abstract | p. 66 |
Introduction | p. 67 |
Monoclonal Antibodies to uPAR | p. 77 |
Immunoassays for the Quantification of uPAR | p. 79 |
uPAR in Cancer | p. 82 |
Other Diseases | p. 91 |
Conclusions and Perspectives | p. 91 |
References | p. 93 |
Proteomics in Cancer | |
Abstract | p. 104 |
Introduction | p. 104 |
Sampling for Proteomic Analysis | p. 106 |
Proteomic Technologies Used in Cancer Proteomics | p. 110 |
Proteomic Applications in Cancer | p. 114 |
What Has Been Achieved in Cancer Proteomics? | p. 127 |
Conclusion | p. 133 |
References | p. 134 |
Paraneoplastic Neurological Syndromes and Onconeural Antibodies: Clinical and Immunological Aspects | |
Abstract | p. 144 |
Introduction | p. 144 |
Onconeural Antigens | p. 148 |
Paraneoplastic Syndromes of the CNS | p. 149 |
PNS of the Peripheral Nervous System | p. 155 |
Paraneoplastic Nervous System Syndromes of the Neuromuscular Junction | p. 159 |
Diagnosis of Paraneoplastic Nervous System Syndromes | p. 159 |
Pathogenesis of Paraneoplastic Nervous System Syndromes | p. 165 |
Therapy for Paraneoplastic Nervous System Syndromes | p. 170 |
Future Aspects | p. 172 |
References | p. 172 |
Pathophysiological Mechanisms of Angiogenesis | |
Abstract | p. 188 |
Introduction | p. 189 |
Measuring the Angiogenic Process | p. 191 |
Endothelial Cells and the Initiation of Angiogenesis | p. 193 |
Differential Angiogenic Pathways | p. 198 |
Impact of the Vessel's Environment on Angiogenesis | p. 204 |
Angiogenesis Biomarkers for Assessing Human Disease | p. 205 |
Therapeutic Targeting of Angiogenesis | p. 210 |
Conclusion | p. 211 |
References | p. 212 |
Bikunin (Urinary Trypsin Inhibitor): Structure, Biological Relevance, and Measurement | |
Abstract | p. 224 |
Introduction | p. 225 |
Roles in Biological Processes | p. 230 |
Diagnostic Testing | p. 233 |
Pathophysiology of Bik | p. 235 |
Summary | p. 240 |
References | p. 240 |
Gene Expression Assays | |
Abstract | p. 248 |
Introduction | p. 248 |
The Technology | p. 250 |
Gene Expression Assays in Cancer | p. 256 |
Applications of Arrays to Neurological Disorders | p. 265 |
Application of Microarrays to Neuropsychiatric Disorders | p. 277 |
Future Advances | p. 281 |
References | p. 282 |
Index | p. 293 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.